Penny Kris-Etherton

Dr. Penny Kris-Etherton


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2011 in Circulation
Verified
Journal Article
Closed access
MMMichael Miller
Michael Miller
NSNeil J. Stone
Neil J. Stone
CBChristie Ballantyne
Christie Ballantyne
VBVera Bittner
Vera Bittner
MCMichael H. Criqui
Michael H. Criqui
SPSubramanian Pennathur
Subramanian Pennathur

22 March 2011 in Circulation
Verified
Journal Article
Closed access
PDF file
LMLori Mosca
Lori Mosca
Emelia J. BenjaminEmelia J. Benjamin
Emelia J. Benjamin
KBKathy Berra
Kathy Berra
JBJudy L. Bezanson
Judy L. Bezanson
RDRowena J. Dolor
Rowena J. Dolor
NWNanette K. Wenger
Nanette K. Wenger

18 July 2017 in Circulation
Verified
Journal Article
Open access
PDF file
FSFrank M. Sacks
Frank M. Sacks
ALAlice H. Lichtenstein
Alice H. Lichtenstein
JWJason Wu
Jason Wu
LALawrence J. Appel
Lawrence J. Appel
MCMark A. Creager
Mark A. Creager
LHLinda V. Van Horn
Linda V. Van Horn
Cardiovascular disease (CVD) is the leading global cause of death, accounting for 17.3 million deaths per year. Preventive treatment that reduces CVD by even a small percentage can substantially reduce, nationally and globally, the number of people who develop CVD and the costs of caring for them. This American Heart Association presidential advisory on dietary fats and CVD reviews and discusses the scientific evidence, including the most recent studies, on the effects of dietary saturated fat intake and its replacement by other types of fats and carbohydrates on CVD. In summary, randomized controlled trials that lowered intake of dietary saturated fat and replaced it with polyunsaturated vegetable oil reduced CVD by ≈30%, similar to the reduction achieved by statin treatment. Prospective observational studies in many populations showed that lower intake of saturated fat coupled with higher intake of polyunsaturated and monounsaturated fat is associated with lower rates of CVD and of other major causes of death and all-cause mortality. In contrast, replacement of saturated fat with mostly refined carbohydrates and sugars is not associated with lower rates of CVD and did not reduce CVD in clinical trials. Replacement of saturated with unsaturated fats lowers low-density lipoprotein cholesterol, a cause of atherosclerosis, linking biological evidence with incidence of CVD in populations and in clinical trials. Taking into consideration the totality of the scientific evidence, satisfying rigorous criteria for causality, we conclude strongly that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD. This recommended shift from saturated to unsaturated fats should occur simultaneously in an overall healthful dietary pattern such as DASH (Dietary Approaches to Stop Hypertension) or the Mediterranean diet as emphasized by the 2013 American Heart Association/American College of Cardiology lifestyle guidelines and the 2015 to 2020 Dietary Guidelines for Americans.

27 July 2010 in Circulation
Verified
Journal Article
Closed access
PDF file
NANancy T. Artinian
Nancy T. Artinian
GFGerald F. Fletcher
Gerald F. Fletcher
DMDariush Mozaffarian
Dariush Mozaffarian
PKPenny Kris-Etherton
Penny Kris-Etherton
LHLinda Van Horn
Linda Van Horn
LBLora E. Burke
Lora E. Burke

1 January 2000 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
PKPenny Kris-Etherton
Penny Kris-Etherton
DTDenise Shaffer Taylor
Denise Shaffer Taylor
SYShaomei Yu-Poth
Shaomei Yu-Poth
PHPeter Huth
Peter Huth
KMKristin Moriarty
Kristin Moriarty
TETerry D Etherton
Terry D Etherton
In the United States, intake of n−3 fatty acids is ≈1.6 g/d (≈0.7% of energy), of which 1.4 g is α-linolenic acid (ALA; 18:3) and 0.1–0.2 g is eicosapentaenoic acid (EPA; 20:5) and docosahexaenoic acid (DHA; 22:6). The primary sources of ALA are vegetable oils, principally soybean and canola. The predominant sources of EPA and DHA are fish and fish oils. Intake data indicate that the ratio of n−6 to n−3 fatty acids is ≈9.8:1. Food disappearance data between 1985 and 1994 indicate that the ratio of n−6 to n−3 fatty acids has decreased from 12.4:1 to 10.6:1. This reflects a change in the profile of vegetable oils consumed and, in particular, an approximate 5.5-fold increase in canola oil use. The ratio of n−6 to n−3 fatty acids is still much higher than that recommended (ie, 2.3:1). Lower ratios increase endogenous conversion of ALA to EPA and DHA. Attaining the proposed recommended combined EPA and DHA intake of 0.65 g/d will require an approximately 4-fold increase in fish consumption in the United States. Alternative strategies, such as food enrichment and the use of biotechnology to manipulate the EPA and DHA as well as ALA contents of the food supply, will become increasingly important in increasing n−3 fatty acid intake in the US population.

1 March 2011 in JACC
Verified
Journal Article
Closed access
LMLori Mosca
Lori Mosca
Emelia J. BenjaminEmelia J. Benjamin
Emelia J. Benjamin
KBKathy Berra
Kathy Berra
JBJudy L. Bezanson
Judy L. Bezanson
RDRowena J. Dolor
Rowena J. Dolor
NWNanette K. Wenger
Nanette K. Wenger